
EMvision Medical Devices Ltd
ASX:EMV

EMvision Medical Devices Ltd
Revenue
EMvision Medical Devices Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
EMvision Medical Devices Ltd
ASX:EMV
|
Revenue
AU$8.6m
|
CAGR 3-Years
76%
|
CAGR 5-Years
56%
|
CAGR 10-Years
N/A
|
|
![]() |
Somnomed Ltd
ASX:SOM
|
Revenue
AU$100.3m
|
CAGR 3-Years
15%
|
CAGR 5-Years
10%
|
CAGR 10-Years
11%
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Revenue
AU$27.6m
|
CAGR 3-Years
16%
|
CAGR 5-Years
14%
|
CAGR 10-Years
9%
|
|
![]() |
Cochlear Ltd
ASX:COH
|
Revenue
AU$2.3B
|
CAGR 3-Years
14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
10%
|
|
![]() |
Optiscan Imaging Ltd
ASX:OIL
|
Revenue
AU$1.3m
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
31%
|
|
![]() |
Austco Healthcare Ltd
ASX:AHC
|
Revenue
AU$58.2m
|
CAGR 3-Years
21%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
EMvision Medical Devices Ltd
Glance View
EMvision Medical Devices Ltd. engages in the development & commercialization of medical imaging technology. The company is headquartered in Brisbane, Queensland. The company went IPO on 2018-12-13. The Company’s principal activity consists of research and development of medical imaging and diagnostic technology for the purpose of commercializing portable medical device for stroke diagnosis and monitoring, as well as other medical imaging needs. The firm is engaged in developing portable brain scanner for stroke diagnosis and monitoring.

See Also
What is EMvision Medical Devices Ltd's Revenue?
Revenue
8.6m
AUD
Based on the financial report for Dec 31, 2024, EMvision Medical Devices Ltd's Revenue amounts to 8.6m AUD.
What is EMvision Medical Devices Ltd's Revenue growth rate?
Revenue CAGR 5Y
56%
Over the last year, the Revenue growth was -3%. The average annual Revenue growth rates for EMvision Medical Devices Ltd have been 76% over the past three years , 56% over the past five years .